Ticker Details
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
IPO Date:	July 6, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$12.3B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 3.51%
Avg Daily Range (30 D):	$2.41 | 2.98%
Avg Daily Range (90 D):	$2.09 | 2.70%

Institutional Daily Volume
Avg Daily Volume:	.84M
Avg Daily Volume (30 D):	1.52M
Avg Daily Volume (90 D):	1.47M

Trade Size
Avg Trade Size (Sh.):	112
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	6,476
Avg Institutional Trade:	$4.13M
Avg Institutional Trade (30 D):	$5.57M
Avg Institutional Trade (90 D):	$8.15M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$7.35M
Avg Closing Trade (30 D):	$22.02M
Avg Closing Trade (90 D):	$30.22M
Avg Closing Volume:	199.27K

News

Jul 15, 2026 @ 8:10 AM Oligonucleotide CDMO Market to Reach USD 9.87 Bill... Source: Researchandmarkets.Com

Apr 30, 2026 @ 5:00 PM Complement Inhibitors Market Outlook Remains Stron... Source: Delveinsight

Apr 29, 2026 @ 5:00 PM IgA Nephropathy Market Forecast to 2036: Novel The... Source: Delveinsight

Feb 13, 2026 @ 6:45 PM CRISPR Therapeutics Spotlights Momentum For Lead G... Source: Vandana Singh

Feb 9, 2026 @ 6:00 PM Idiopathic Pulmonary Fibrosis Clinical Trials & Pi... Source: Delveinsight

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-2.28	$-1.36	$-.93
Diluted EPS	$-2.28	$-1.36	$-.93
Revenue	$669.5M	$75.25M	$73.74M
Gross Profit
Net Income / Loss	$-272.13M	$-178.92M	$-137.57M
Operating Income / Loss	$-226.44M	$-170.09M	$-141.26M
Cost of Revenue
Net Cash Flow	$-76.99M	$-134.24M	$-14.23M
PE Ratio

Splits
Nov 17, 2011	1:10
Jan 15, 2004	1:65